Literature DB >> 32168083

Myocardial Mechanics Parameters That Predict Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy: A Cardiovascular Magnetic Resonance Feature Tracking Analysis.

Lei Huang, Lifeng Que1, Yue Xi1, Jian Zhuang2, Haiyun Yuan2, Hui Liu1, Jinglei Li2, Yuhao Dong3, Qianjun Jia3, JiJin Lin.   

Abstract

OBJECTIVE: To identify left ventricular (LV) myocardial mechanics predictors of LV outflow tract obstruction (LVOTO) in patients with hypertrophic cardiomyopathy (HCM).
METHODS: Thirty-nine adults with HCM and 21 controls underwent cardiovascular magnetic resonance. The feature tracking (FT) analysis results of HCM patients with and without LVOTO and controls were compared.
RESULTS: Global radial strain measured on the short-axis slice (GRS-SAX) (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.02-1.15; P < 0.01), global longitudinal strain measured on the long-axis slice (GLS-LAX) (OR, 1.81; 95% CI, 1.21-2.73; P < 0.01) and GRS measured on the long-axis slice (GRS-LAX) (OR, 1.07; 95% CI, 1.01-1.13; P = 0.02) were independent predictors of LVOTO. The combination of GRS-SAX plus GLS-LAX and GRS-LAX showed great discriminatory power for identifying LVOTO with an area under the receiver operating characteristic curve value of 0.91 (95% CI: 0.81-1.00).
CONCLUSIONS: In adult HCM patients, GRS-SAX, GLS-LAX, and GRS-LAX were independent predictors of LVOTO. The combination of GRS-SAX plus GLS-LAX and GRS-LAX showed great discriminatory power for identifying LVOTO.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 32168083     DOI: 10.1097/RCT.0000000000000977

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

1.  The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.

Authors:  Shengliang Liu; Yunling Li; Yanming Zhao; Xueying Wang; Zhiyuan Wu; Xia Gu; Bing Xu; Ye Li; Jinwei Tian; Jinjin Cui; Guokun Wang; Bo Yu
Journal:  Front Cardiovasc Med       Date:  2022-05-11

Review 2.  A Perspective on Personalized Therapies in Hypertrophic Cardiomyopathy.

Authors:  Paul H Goldspink; Chad M Warren; Jan Kitajewski; Beata M Wolska; R John Solaro
Journal:  J Cardiovasc Pharmacol       Date:  2021-03-01       Impact factor: 3.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.